iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionKrilogy Financial LLC
Latest Disclosed Ownership3,614 shares
Latest Disclosed Value $ 629,294
Krilogy Financial LLC reports 2.15% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 17, 2026 - Krilogy Financial LLC filed a 13F-HR form disclosing ownership of 3,614 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $629,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 3,538 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 2.15% during the quarter. The current value of the position is $473,615 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,614 76 2.15 629 1.13 0.0203
2026-01-27 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,538 -54 -1.50 622 9.51 0.0212
2025-11-06 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,592 3,592 569 0.0214
2023-07-19 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,815 -100.00 0 -100.00
2023-05-03 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,815 -3,739 -67.32 234 -67.90 0.0197
2023-02-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 5,554 5,554 729 0.0694
2022-10-06 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,717 -100.00 0 -100.00
2022-07-14 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,717 -405 -19.09 202 -26.81 0.0235
2022-04-28 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,122 -4 -0.19 276 -14.81 0.0282
2022-01-27 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,126 -75 -3.41 324 -8.99 0.0326
2021-10-25 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,201 104 4.96 356 3.79 0.0355
2021-07-20 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,097 0 0.00 343 8.54 0.0342
2021-04-21 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,097 153 7.87 316 7.12 0.0334
2021-02-11 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,944 190 10.83 295 24.47 0.0354
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,754 -111 -5.95 237 -7.06 0.0329
2020-08-06 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,865 1,865 255 0.0391
2020-05-13 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,343 -100.00 0 -100.00
2020-02-12 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,343 2,343 282 0.0464
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -1,906 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,906 113 6.30 208 3.48 0.0399
2019-05-14 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,793 1,793 201 0.0425
2019-02-14 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,081 -100.00 0 -100.00
2018-11-13 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,081 2,081 254 0.0576
2018-08-15 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -1,496 -100.00 0 -100.00
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,496 342 29.64 160 30.08 0.0382
2018-02-14 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,154 807 232.56 123 6.03 0.0297
2017-11-15 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 347 0 0.00 116 7.41 0.0296
2017-08-15 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 347 -1 -0.29 108 17.39 0.0302
2017-05-16 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 348 0 0.00 92 0.00 0.0286
2017-02-15 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 348 -327 -48.44 92 -52.82 0.0286
2016-11-15 2016-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 675 -126 -15.73 195 -5.34 0.0619
2016-08-16 2016-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 801 682 573.11 206 564.52 0.0716
2016-05-13 2016-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 119 119 0.00 31 0.0128
2016-02-29 2015-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -48 -100.00 0 -100.00
2015-11-25 2015-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 48 48 15 0.0071
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.